Poly(ADP)-Ribose Polymerase Inhibition: Frequent Durable Responses in <i>BRCA</i> Carrier Ovarian Cancer Correlating With Platinum-Free Interval

2010989 citationsJournal Articlebronze Open Access

Authors

Olaparib has antitumor activity in BRCA1/2 mutation ovarian cancer, which is associated with platinum sensitivity.

Good health and well-being

Published in: Journal of Clinical Oncology

Volume 28, Issue 15, pp. 2512-2519

Field-Weighted Citation Impact: 43.83